Axsome Therapeutics, Inc. has three marketed CNS drugs and pipeline potential in Alzheimer's and narcolepsy. Read why AXSM stock is a buy.
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare evolves towards proactive, ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As sleep disorders such as obstructive sleep apnea ...
Researchers at WashU Medicine and their collaborators have found that newborns who receive surgery for a severe form of spina bifida are more likely to suffer from breathing disruptions during sleep ...
Many people think that snoring is just a normal part of sleep. But for some, it can be a sign of a serious and often ignored ...
Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.
Middle-aged adults with comorbid insomnia and sleep apnea faced significantly elevated odds for uncontrolled hypertension vs. adults without these conditions, according to results published in Annals ...
Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.
Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...
While many articles reference common experiences like exhaustion, work-life balance, and health challenges when addressing ...
KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results